Prevention of graft rejection by donor type II CD8(+) T cells (Tc2 cells) is not sufficient to improve engraftment in fetal transplantation.
about
Cellular therapies supplement: the peritoneum as an ectopic site of hematopoiesis following in utero transplantation.Postnatal donor lymphocytes enhance prenatally-created chimerism at the risk of graft-versus-host disease.In utero transplantation: baby steps towards an effective therapy.Persistence of allografts in the peritoneal cavity after prenatal transplantation in mice.Characterization of Tolerance Induction through Prenatal Marrow Transplantation: The Requirement for a Threshold Level of Chimerism to Establish Rather than Maintain Postnatal Skin Tolerance
P2860
Prevention of graft rejection by donor type II CD8(+) T cells (Tc2 cells) is not sufficient to improve engraftment in fetal transplantation.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Prevention of graft rejection ...... ment in fetal transplantation.
@ast
Prevention of graft rejection ...... ment in fetal transplantation.
@en
type
label
Prevention of graft rejection ...... ment in fetal transplantation.
@ast
Prevention of graft rejection ...... ment in fetal transplantation.
@en
prefLabel
Prevention of graft rejection ...... ment in fetal transplantation.
@ast
Prevention of graft rejection ...... ment in fetal transplantation.
@en
P2093
P2860
P356
P1476
Prevention of graft rejection ...... ment in fetal transplantation.
@en
P2093
Hanmin Lee
Jeng-Chang Chen
Ming-Ling Chang
P2860
P356
10.1159/000081367
P577
2005-01-01T00:00:00Z